Experimental women's cancer drug boosts survival rates in notable study A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer. Researchers discuss the findings. Original Source: https://www.foxnews.com/health/experimental-womens-cancer-drug-boosts-survival-rates-notable-study
